Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.50 |
| ▸ | MAPT | P10636 | 6/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 3/20 | 0.50 |
| ▸ | GLA | P06280 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30463062 | 1.00 | KMT2A (0.50) | KMT2AMAPTTDP1MEN1LMNA | |
| SCHEMBL4333864 | 0.86 | LMNA (0.60) | KMT2ATDP1MEN1LMNAGAA | |
| SCHEMBL20518486 | 0.84 | MEN1 (0.48) | KMT2AMAPTTDP1MEN1LMNA | |
| SCHEMBL2559807 | 0.84 | MEN1 (0.43) | KMT2AMAPTTDP1MEN1LMNA | |
| SCHEMBL8923358 | 0.84 | NPC1 (0.58) | KMT2AMAPTTDP1MEN1LMNA | |
| SCHEMBL28685037 | 0.83 | HSD17B10 (0.46) | KMT2AMAPTTDP1MEN1LMNA | |
| SCHEMBL21048723 | 0.81 | FABP4 (0.54) | KMT2AMAPTTDP1MEN1LMNA | |
| SCHEMBL22571419 | 0.80 | MEN1 (0.44) | KMT2AMAPTTDP1MEN1LMNA | |
| SCHEMBL14306852 | 0.80 | ABCG2 (0.43) | KMT2AMAPTMEN1HPGDPTGS1 | |
| SCHEMBL6308388 | 0.80 | NPC1 (0.53) | KMT2AMAPTTDP1MEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118976383-A | Polytetrafluoroethylene microporous membrane, hydrophilic modification method thereof and water treatment device | 浙江东大环境工程有限公司 | 2024-11-19 | — | — | CN | claimed |
| US-20250261501-A1 | LIGHT EMITTING ELEMENT AND METHOD FOR PRODUCING THE SAME, LIGHT EMITTING COMPOUND AND METHOD FOR PRODUCING THE SAME, COMPOSITION AND METHOD FOR PRODUCING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-08-14 | — | — | US | disclosed |
| EP-4498778-A1 | LIGHT-EMITTING ELEMENT AND PRODUCTION METHOD THEREFOR, LIGHT-EMITTING COMPOUND AND PRODUCTION METHOD THEREFOR, COMPOSITION AND PRODUCTION METHOD THEREFOR, INFORMATION PROCESSING METHOD, INFORMATION PROCESSING DEVICE, PROGRAM, METHOD FOR PROVIDING LIGHT-EMITTING COMPOUND, AND DATA GENERATION METHOD | Sumitomo Chemical Company, Limited (JP) | 2025-01-29 | — | — | EP | disclosed |
| CN-119192442-A | Material for hydrophilic modification of polytetrafluoroethylene microporous membrane and preparation method thereof | 浙江东大环境工程有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-119014139-A | Light-emitting element and method for producing same, light-emitting compound and method for producing same, composition and method for producing same, information processing method, information processing device, computer program product, method for providing light-emitting compound, and method for generating data | 住友化学株式会社 | 2024-11-22 | — | — | CN | disclosed |
| CN-118976383-A | Polytetrafluoroethylene microporous membrane, hydrophilic modification method thereof and water treatment device | 浙江东大环境工程有限公司 | 2024-11-19 | — | — | CN | disclosed |
| WO-2023181958-A1 | LIGHT-EMITTING ELEMENT AND PRODUCTION METHOD THEREFOR, LIGHT-EMITTING COMPOUND AND PRODUCTION METHOD THEREFOR, COMPOSITION AND PRODUCTION METHOD THEREFOR, INFORMATION PROCESSING METHOD, INFORMATION PROCESSING DEVICE, PROGRAM, METHOD FOR PROVIDING LIGHT-EMITTING COMPOUND, AND DATA GENERATION METHOD | 住友化学株式会社 | 2023-09-28 | — | — | WO | disclosed |
| EP-3464317-B1 | AMINOSTEROID DERIVATIVES AND PROCESS FOR PRODUCING SAME | UNIV LAVAL (CA) | 2023-04-26 | — | — | EP | disclosed |
| US-11174282-B2 | Aminosteroid derivatives and process for producing same | UNIVERSITé LAVAL (CA) | 2021-11-16 | — | — | US | disclosed |
| CN-112574202-B | Spiroquinazoline-2-ketone derivative and preparation method and application thereof | 台州学院 | 2021-11-09 | — | — | CN | disclosed |
| EP-2043644-A1 | NF- B INHIBITOR | Otsuka Pharmaceutical Co., Ltd. (JP) | 2009-04-08 | — | — | EP | disclosed |
| WO-2008010601-A1 | NF- ϰB INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-01-24 | — | — | WO | disclosed |
| US-20080021085-A1 | METHOD OF REDUCING ABETA42 AND TREATING DISEASES | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2008-01-24 | — | — | US | disclosed |
| US-20070179173-A1 | Carbostyril compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-02 | — | — | US | disclosed |
| EP-1797082-A1 | CARBOSTYRIL COMPOUND | Otsuka Pharmaceutical Company, Limited (JP) | 2007-06-20 | — | — | EP | disclosed |
| WO-2006035954-A1 | CARBOSTYRIL COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-04-06 | — | — | WO | disclosed |
| US-6555663-B1 | Pharmaceuticals which are activated intracellularly by reaction with cellular electron carriers or free radicals to cause release of a free and active drug molecule | MILLS RANDELL LEE (US) | 2003-04-29 | — | — | US | disclosed |
| US-5703119-A | ANTIARTHRITIC AGENTS | WARNER-LAMBERT COMPANY (US) | 1997-12-30 | — | — | US | disclosed |
| US-5428163-A | Luminides; chemiluminescence; redox system, releasing free drug | MILLS RANDELL L (US) | 1995-06-27 | — | — | US | disclosed |
| US-5358964-A | Antiarthritic agents | WARNER-LAMBERT COMPANY (US) | 1994-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070179173-A1 | Carbostyril compound | GTF2F1, F3, GTF2F2 | KMT2A 2732/4885MAPT 4773/4885TDP1 4079/4885 |
| US-20080021085-A1 | METHOD OF REDUCING ABETA42 AND TREATING DISEASES | BACE1, BACE2, APP | KMT2A 1301/4885MAPT 80/4885TDP1 294/4885 |
| US-11174282-B2 | Aminosteroid derivatives and process for producing same | HSD17B11, HSD17B7, CYP19A1 | KMT2A 3255/4885MAPT 3922/4885TDP1 4837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.